Business Today
Subscribe
NRICareer & JobsUS NewsMake In IndiaIn PicsWeatherFuel PricesPMS TodayBT Reels
BT India at 100BT Infra SummitEY Business Today Hidden Gems 2026
Search
Advertisement
Business News
markets
stocks
Emcure Pharmaceuticals Ltd
Emcure Pharmaceuticals Ltd

Emcure Pharmaceuticals Ltd (EMCURE) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 32,384
Sep 25, 2026
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹1,950.60
₹-1.50 (-0.08%)
1,931.50Low
Today’s Performance
1,976.90High
1,260.00Low
52 Week’s Performance
2,100.70High

Stock Analysis

Stock Performance

  • 1 Day-0.08%
  • 1 Week-2.65%
  • 1 Month5.61%
  • 3 Months3.74%
  • 6 Months22.42%
  • 1 Year47.13%
  • 3 Years12.80%
  • 5 Years-%

Company Stories

Adani Power, Samman, IMFA, UBL, Emcure among stocks with fresh brokerage interest for upto 140% riseBrokerages turn bullish on 11 stocks including Adani Power, PhysicsWallah, SEAMEC and Emcure Pharma, seeing up to 140% upside. Check ratings and targets.AI-generated image for representational purpose only.
    View more

    Stock Summary

    • Face Value (₹)10.00
    • Beta0.49
    • 52-Week Low (₹)1,260.00
    • 52-Week High (₹)2,100.70
    • Price-to-Book (X)*7.45
    • Dividend Yield (%)0.18
    • Price-to-Earnings (P/E) (X)*36.22
    • Earnings Per Share (₹)53.71
    • Market Cap (₹ Cr.)*37,004.96
    * Values as of last close price

    COMPETITORS

    BT TV

    How Is Alexa+ Different? Will It have Ads Even If You Pay? Exclusive Chat7:10How Is Alexa+ Different? Will It have Ads Even If You Pay? Exclusive Chat
    Demand Robust Across Segments | Production To Ramp Up, Exports To Expand: Vivek Srivatsa10:37Demand Robust Across Segments | Production To Ramp Up, Exports To Expand: Vivek Srivatsa
    GST Council To Meet On October 7: Invoice Matching, ITC & UPI MDR Tax In Focus2:08GST Council To Meet On October 7: Invoice Matching, ITC & UPI MDR Tax In Focus
    Tata Chip Plans Stay On Track Despite Boardroom Rift | Dholera Fab Investment Unaffected3:46Tata Chip Plans Stay On Track Despite Boardroom Rift; Dholera Fab Investment Unaffected
    GLP-1 Drugs Face Eye Safety Concerns: Will Fresh Scrutiny Impact India's Growing Market?5:24GLP-1 Drugs Face Eye Safety Concerns: Will Fresh Scrutiny Impact India's Growing Market?
    Inside Tata’s Biggest Boardroom Battle: Noel Tata Vs N Chandrasekaran Explained | Hitesh Jain23:35Inside Tata’s Biggest Boardroom Battle: Noel Tata Vs N Chandrasekaran Explained | Hitesh Jain
    FPIs Allowed In Commodity Derivatives: How SEBI Plans To Deepen Market Liquidity4:07FPIs Allowed In Commodity Derivatives: How SEBI Plans To Deepen Market Liquidity
    IRDAI Commission Caps Explained | Will Insurance Get Cheaper? | Who Gains, Who Loses?23:45IRDAI Commission Caps Explained | Will Insurance Get Cheaper? | Who Gains, Who Loses?
    Bond Crisis Worsens | U.S. 30-Year Treasury Yield Hits 2004 High | Explained: Why Yields Are Rising24:18Bond Crisis Worsens | U.S. 30-Year Treasury Yield Hits 2004 High | Explained: Why Yields Are Rising
    Market Commentary LIVE | Top Gainers, Losers & Trading Strategy | Chandan Taparia17:52Market Commentary | Top Gainers, Losers & Trading Strategy | Chandan Taparia
    View more

    FAQs

    What was Emcure Pharmaceuticals Ltd share price previously?
    Emcure Pharmaceuticals Ltd share price was down by -0.08% from the previous closing price of ₹1,952.10.
    Who are peers of Emcure Pharmaceuticals Ltd?
    The peers of Emcure Pharmaceuticals Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Zydus Lifesciences Ltd, Cipla Ltd.
    Who is/are the promoter/promoters of Emcure Pharmaceuticals Ltd?
    The promotor/promotors of Emcure Pharmaceuticals Ltd are MUKUND KESHAO GURJAR, SATISH RAMANLAL MEHTA, NAMITA VIKAS THAPAR, SAMIT SATISH MEHTA, Vidya Rajiv Yeravdekar, Vijay Gokhale, Shailesh Ayyangar, Samonnoi Banerjee, Amruta Jana Yangalwar, RAMAN PILLAI RAGHU KUMAR.
    What has been 52-week high of Emcure Pharmaceuticals Ltd stocks?
    The highest price of Emcure Pharmaceuticals Ltd stock is ₹2,100.70 in the last 52-week.
    What is the share price of Emcure Pharmaceuticals Ltd (EMCURE) today on NSE?
    As on Sep 25, 2026 Emcure Pharmaceuticals Ltd (EMCURE)’s share price on NSE is Rs 1950.6
    What is the market cap of Emcure Pharmaceuticals Ltd (EMCURE)?
    The current market capitalisation of Emcure Pharmaceuticals Ltd (EMCURE) is 37,004.96 crores
    What is Emcure Pharmaceuticals Ltd Share symbol?
    The symbol of Emcure Pharmaceuticals Ltd is EMCURE.
    What is the PE ratio of Emcure Pharmaceuticals Ltd (EMCURE)?
    The current PE ratio of Emcure Pharmaceuticals Ltd (EMCURE) is 36.22.
    What is the PB ratio of Emcure Pharmaceuticals Ltd (EMCURE)?
    The current PB ratio of Emcure Pharmaceuticals Ltd (EMCURE) is 7.45.
    Today’s High & Low share prices of Emcure Pharmaceuticals Ltd (EMCURE) on NSE?
    Today, the share price of Emcure Pharmaceuticals Ltd (EMCURE) on NSE touched a high of Rs 1976.9 and a low of Rs 1931.5
    What price did Emcure Pharmaceuticals Ltd (EMCURE) shares open on the NSE today?
    On NSE, the share price of Emcure Pharmaceuticals Ltd (EMCURE) opened at Rs 1958.7
    What is the 52-week high of Emcure Pharmaceuticals Ltd (EMCURE)?
    The 52-week high price of Emcure Pharmaceuticals Ltd (EMCURE) is Rs 2,100.70
    What is the 52-week low of Emcure Pharmaceuticals Ltd (EMCURE)?
    The 52-week low price of Emcure Pharmaceuticals Ltd (EMCURE) is Rs 1,260.00

    About Emcure Pharma

    Emcure Pharmaceuticals Ltd, incorporated in the year 1981, has its registered office in Plot # P-1 & P-2 IT BT Park, Phase II MIDC Hinjawadi, Pune, Maharashtra, 411057, +91 20 3507 0033/+91 20 3507 0000. The main industry in which Emcure Pharmaceuticals Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

    Auditor/Auditors for Emcure Pharmaceuticals Ltd is/are BSR & Co LLP. In the main management, SATISH RAMANLAL MEHTA is chairman and Amruta Jana Yangalwar is the company secretary for Emcure Pharmaceuticals Ltd.

    • MKG
      MUKUND KESHAO GURJARWhole Time Director
    • SRM
      SATISH RAMANLAL MEHTACMD & CEO
    • NVT
      NAMITA VIKAS THAPARWhole-time Director
    • SSM
      SAMIT SATISH MEHTAWhole Time Director & COO
    • VRY
      Vidya Rajiv YeravdekarIndependent Director
    • VG
      Vijay GokhaleIndependent Director
    • SA
      Shailesh AyyangarIndependent Director
    • SB
      Samonnoi BanerjeeNon Executive Director
    • AJY
      Amruta Jana YangalwarCompany Sec. & Compli. Officer
    • RPRK
      RAMAN PILLAI RAGHU KUMARAdditional Director

    Top Stories

    DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

    DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

    By using this website, you agree to the Terms of Service and Privacy Policy.